EPS for Medifast, Inc. (MED) Expected At $0.48

February 19, 2018 - By Larry Anderson

 EPS for Medifast, Inc. (MED) Expected At $0.48
Investors sentiment decreased to 1 in 2017 Q3. Its down 0.11, from 1.11 in 2017Q2. It worsened, as 15 investors sold Medifast, Inc. shares while 60 reduced holdings. 31 funds opened positions while 44 raised stakes. 10.20 million shares or 2.70% less from 10.48 million shares in 2017Q2 were reported.
Moreover, Schroder Inv Grp has 0% invested in Medifast, Inc. (NYSE:MED) for 23,921 shares. Ingalls & Snyder Ltd Company has invested 0.25% in Medifast, Inc. (NYSE:MED). Tennessee-based State Of Tennessee Treasury Department has invested 0% in Medifast, Inc. (NYSE:MED). Bnp Paribas Arbitrage Sa holds 0% or 5,706 shares in its portfolio. Intl Gp Incorporated reported 8,381 shares stake. Guggenheim Capital Limited Co holds 0% or 7,897 shares in its portfolio. Morgan Stanley owns 74,337 shares. Acadian Asset Llc accumulated 451,185 shares or 0.12% of the stock. North Star Invest Mgmt, a Illinois-based fund reported 800 shares. Northern Tru Corporation holds 0% or 137,160 shares in its portfolio. The Switzerland-based Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% in Medifast, Inc. (NYSE:MED). First Manhattan Com stated it has 0% of its portfolio in Medifast, Inc. (NYSE:MED). Brown Advisory reported 15,090 shares or 0% of all its holdings. Meeder Asset Mgmt Incorporated owns 1,923 shares or 0.01% of their US portfolio. Eqis Cap Mngmt invested in 0.07% or 20,609 shares.

Analysts expect Medifast, Inc. (NYSE:MED) to report $0.48 EPS on March, 8.They anticipate $0.14 EPS change or 41.18 % from last quarter’s $0.34 EPS. MED’s profit would be $5.73 million giving it 35.99 P/E if the $0.48 EPS is correct. After having $0.55 EPS previously, Medifast, Inc.’s analysts see -12.73 % EPS growth. The stock decreased 0.09% or $0.06 during the last trading session, reaching $69.11. About 71,797 shares traded. Medifast, Inc. (NYSE:MED) has risen 25.81% since February 19, 2017 and is uptrending. It has outperformed by 9.11% the S&P500.

Medifast, Inc. (NYSE:MED) Ratings Coverage

Among 3 analysts covering Medifast (NYSE:MED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Medifast had 7 analyst reports since August 10, 2015 according to SRatingsIntel. The company was maintained on Friday, September 15 by DA Davidson. The stock has “Buy” rating by Sidoti on Monday, October 5. The firm has “Hold” rating by Zacks given on Monday, August 10. On Monday, November 30 the stock rating was downgraded by Sidoti to “Neutral”. Wunderlich initiated it with “Hold” rating and $32 target in Friday, January 29 report. DA Davidson initiated it with “Buy” rating and $65.0 target in Wednesday, August 16 report. Sidoti upgraded the stock to “Buy” rating in Monday, January 11 report.

Medifast, Inc., through its subsidiaries, produces, distributes, and sells weight loss, weight management, healthy living products, and other consumable health and diet products. The company has market cap of $824.73 million. The firm offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, eggs, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape For Life, Flavors of Home, and Essential 1 brands, as well as Dual Fuel, a sports nutrition pilot program. It has a 34.03 P/E ratio. It also provides meal replacements comprising vitamins and minerals; and hydration products, as well as other nutrients for health purposes.

More notable recent Medifast, Inc. (NYSE:MED) news were published by: Prnewswire.com which released: “Medifast, Inc. Announces 50 Percent Increase in Quarterly Dividend” on December 06, 2017, also Prnewswire.com with their article: “Medifast, Inc. Announces Third Quarter 2017 Financial Results” published on November 07, 2017, Prnewswire.com published: “Medifast® Announces New Corporate Headquarters in Baltimore City” on September 18, 2017. More interesting news about Medifast, Inc. (NYSE:MED) were released by: Prnewswire.com and their article: “Take Shape For Life® Rebrands to OPTAVIAâ„¢” published on July 24, 2017 as well as Prnewswire.com‘s news article titled: “Medifast, Inc. Announces Second Quarter 2017 Financial Results” with publication date: August 08, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: